Utah Medical Products, Inc. (FRA:UTM)
Germany · Delayed Price · Currency is EUR 47.00
+0.20 (0.43%)
At close: Nov 28, 2025
Utah Medical Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 38.63 | 40.9 | 50.22 | 52.28 | 49.05 | 42.18 | Upgrade | |
Revenue Growth (YoY) | -12.35% | -18.56% | -3.94% | 6.58% | 16.30% | -10.08% | Upgrade |
Cost of Revenue | 16.57 | 16.76 | 20.19 | 20.09 | 18.14 | 16.63 | Upgrade |
Gross Profit | 22.06 | 24.14 | 30.04 | 32.2 | 30.92 | 25.55 | Upgrade |
Selling, General & Admin | 8.28 | 7.6 | 11.04 | 11.91 | 11.51 | 11.35 | Upgrade |
Research & Development | 0.58 | 0.81 | 0.56 | 0.49 | 0.53 | 0.49 | Upgrade |
Operating Expenses | 8.86 | 8.41 | 11.6 | 12.41 | 12.04 | 11.84 | Upgrade |
Operating Income | 13.21 | 15.73 | 18.44 | 19.79 | 18.88 | 13.71 | Upgrade |
Interest & Investment Income | 3.85 | 3.37 | 3.04 | 0.66 | 0.17 | 0.11 | Upgrade |
Currency Exchange Gain (Loss) | -0.02 | 0 | -0.01 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -1.1 | -0.16 | 0.28 | 0.21 | 0.02 | 0.02 | Upgrade |
EBT Excluding Unusual Items | 15.93 | 18.94 | 21.75 | 20.66 | 19.06 | 13.84 | Upgrade |
Legal Settlements | -1.31 | -2.14 | -1.66 | - | - | - | Upgrade |
Pretax Income | 14.62 | 16.8 | 20.09 | 20.66 | 19.06 | 13.84 | Upgrade |
Income Tax Expense | 3 | 2.93 | 3.45 | 4.19 | 4.27 | 3.04 | Upgrade |
Net Income | 11.62 | 13.87 | 16.64 | 16.47 | 14.79 | 10.8 | Upgrade |
Net Income to Common | 11.62 | 13.87 | 16.64 | 16.47 | 14.79 | 10.8 | Upgrade |
Net Income Growth | -23.83% | -16.60% | 0.98% | 11.39% | 36.95% | -26.68% | Upgrade |
Shares Outstanding (Basic) | 3 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 3 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | -7.79% | -3.68% | -0.16% | -0.46% | -0.33% | -1.79% | Upgrade |
EPS (Basic) | 3.54 | 3.96 | 4.58 | 4.53 | 4.05 | 2.95 | Upgrade |
EPS (Diluted) | 3.54 | 3.96 | 4.57 | 4.52 | 4.04 | 2.94 | Upgrade |
EPS Growth | -17.42% | -13.42% | 1.20% | 11.88% | 37.41% | -25.36% | Upgrade |
Free Cash Flow | 13.88 | 14.6 | 21.64 | 20.34 | 20.65 | 19.28 | Upgrade |
Free Cash Flow Per Share | 4.22 | 4.17 | 5.95 | 5.58 | 5.64 | 5.25 | Upgrade |
Dividend Per Share | 1.220 | 1.205 | 1.185 | 1.165 | 0.855 | 1.120 | Upgrade |
Dividend Growth | 1.67% | 1.69% | 1.72% | 36.26% | -23.66% | 1.82% | Upgrade |
Gross Margin | 57.10% | 59.03% | 59.81% | 61.58% | 63.03% | 60.57% | Upgrade |
Operating Margin | 34.18% | 38.46% | 36.71% | 37.85% | 38.49% | 32.50% | Upgrade |
Profit Margin | 30.08% | 33.92% | 33.12% | 31.51% | 30.15% | 25.60% | Upgrade |
Free Cash Flow Margin | 35.93% | 35.70% | 43.09% | 38.90% | 42.10% | 45.70% | Upgrade |
EBITDA | 16.13 | 18.53 | 24.75 | 26.82 | 26.16 | 20.88 | Upgrade |
EBITDA Margin | 41.75% | 45.30% | 49.28% | 51.30% | 53.33% | 49.50% | Upgrade |
D&A For EBITDA | 2.92 | 2.8 | 6.32 | 7.03 | 7.28 | 7.17 | Upgrade |
EBIT | 13.21 | 15.73 | 18.44 | 19.79 | 18.88 | 13.71 | Upgrade |
EBIT Margin | 34.18% | 38.46% | 36.71% | 37.85% | 38.49% | 32.50% | Upgrade |
Effective Tax Rate | 20.50% | 17.43% | 17.19% | 20.26% | 22.42% | 21.98% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.